Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    NANODELIVERY 2018 - 2nd International Conference and Exhibition on Nanomedicine and Drug Delivery

    View: 333

    Website https://nanomedicine.pharmaceuticalconferences.com/ | Want to Edit it Edit Freely

    Category NANODELIVERY 2018

    Deadline: May 20, 2018 | Date: May 21, 2018-May 23, 2018

    Venue/Country: Hilton Tokyo Narita 56 Kosuge, Narita, Chiba Prefe, Japan

    Updated: 2018-01-17 17:31:16 (GMT+9)

    Call For Papers - CFP

    Conference Series LLC is a renowned organization that organizes highly notable Pharmaceutical Conferences throughout the globe. Currently we are bringing forth “2nd International Conference on Nanomedicine and Drug Delivery” (NanoDelivery 2018) scheduled to be held during May 21-23, 2018 at Tokyo, Japan. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Nanomedicine and Drug Delivery. Nanomedicine

    Design of Nanodrugs

    Nanomedicine and Nanotechnology

    Synthesis of Nanoparticles for Drug Delivery

    Regenerative Medicine and Tissue Engineering

    Nanomedicine in Theranostics

    Nanomedicines and Biomedical Applications

    Drug Delivery Research

    Novel Drug Delivery Systems

    Smart Drug Delivery Technology

    Nano Pharmaceuticals

    Nano Biotechnology

    Nano Pharmaceutical Industry and Market

    Regulatory Aspects Towards Approval of Nanomedicine


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.